Rx Rundown: AbbVie, Biogen, GSK and more
Deals: AbbVie announced a $1.4 billion acquisition of Aliada Therapeutics. AbbVie and Gedeon Richter announced collaboration for the discovery and development of novel targets for neuropsychiatric conditions. AbbVie and EvolveImmune Therapeutics announced …